Shingrix to replace Zostavax with lower age cut-off in NIP shake-up
The recombinant herpes zoster vaccine, Shingrix, will soon replace the live-attenuated vaccine, Zostavax, on the National Immunisation Program following advice from the PBAC and ATAGI,…